Alan Scott Enterprises Ltd
Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes
- Market Cap ₹ 152 Cr.
- Current Price ₹ 266
- High / Low ₹ 404 / 92.0
- Stock P/E
- Book Value ₹ 14.2
- Dividend Yield 0.00 %
- ROCE -14.2 %
- ROE -142 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 18.8 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -3.34%
- Company has a low return on equity of -127% over last 3 years.
- Earnings include an other income of Rs.1.23 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 0.02 | 1.24 | 5.17 | 11.42 | 28.69 | 34.45 | |
| 0.11 | 1.90 | 5.60 | 11.47 | 26.75 | 32.20 | |
| Operating Profit | -0.09 | -0.66 | -0.43 | -0.05 | 1.94 | 2.25 |
| OPM % | -450.00% | -53.23% | -8.32% | -0.44% | 6.76% | 6.53% |
| 0.09 | 0.67 | 0.06 | 0.35 | 2.25 | 1.23 | |
| Interest | 0.00 | 0.02 | 0.61 | 1.38 | 2.20 | 2.75 |
| Depreciation | 0.00 | 0.05 | 1.08 | 2.41 | 3.80 | 4.08 |
| Profit before tax | 0.00 | -0.06 | -2.06 | -3.49 | -1.81 | -3.35 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | ||
| 0.00 | -0.07 | -2.06 | -3.50 | -1.82 | -3.36 | |
| EPS in Rs | 0.00 | -0.11 | -3.50 | -6.48 | -3.37 | -4.41 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 185% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 44% |
| 5 Years: | 86% |
| 3 Years: | 115% |
| 1 Year: | 135% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -88% |
| 3 Years: | -127% |
| Last Year: | -142% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1.19 | 1.83 | 1.83 | 3.62 | 3.63 | 5.45 |
| Reserves | 0.35 | 1.25 | -0.64 | -0.26 | -1.86 | 2.65 |
| 0.05 | 0.17 | 3.00 | 8.62 | 7.38 | 11.72 | |
| 0.00 | 2.32 | 6.20 | 15.87 | 18.10 | 15.55 | |
| Total Liabilities | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.37 |
| 0.00 | 2.60 | 6.01 | 15.03 | 15.82 | 16.96 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59 |
| Investments | 0.30 | 0.21 | 0.21 | 0.89 | 1.36 | 2.94 |
| 1.29 | 2.76 | 4.17 | 11.93 | 10.07 | 13.88 | |
| Total Assets | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.37 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0.18 | -1.58 | -2.78 | -3.11 | -1.68 | |
| -0.21 | -0.95 | 0.31 | -3.05 | 0.10 | |
| 1.29 | 1.73 | 2.15 | 8.53 | -0.15 | |
| Net Cash Flow | 1.26 | -0.80 | -0.33 | 2.37 | -1.74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 0.00 | 2.94 | 0.71 | 13.10 | 7.89 |
| Inventory Days | 124.03 | 227.11 | 211.75 | 88.66 | |
| Days Payable | 88.59 | 107.76 | 126.84 | 15.87 | |
| Cash Conversion Cycle | 0.00 | 38.38 | 120.06 | 98.01 | 80.68 |
| Working Capital Days | -730.00 | 73.59 | -46.60 | -70.63 | 26.33 |
| ROCE % | -27.63% | -35.79% | -26.39% | -14.21% |
Documents
Announcements
-
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended December 31, 2025
9 Feb - Raised INR 675.00 lakh via preferential issue on Dec 1, 2025; no utilization deviation; INR109.39 lakh utilized.
-
Announcement under Regulation 30 (LODR)-Acquisition
9 Feb - Approved Dec 31, 2025 results; acquisitions across five entities totaling INR 4.83 crore.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, February 09, 2026, At 11:00 AM (IST) At The Registered Office Of The Company.
9 Feb - Board approved results; used preferential-issue proceeds to buy stakes in five firms totaling ~INR4.83 crore on Feb 9, 2026.
- Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Month Ended December 31, 2025 Along With Limited Review Report Of The Auditors As Per Regulation 33 Of SEBI (Listing Obligations And Disclosures Requirements), Regulations 2015 9 Feb
-
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended December 31, 2025.
3 Feb - Board meeting Feb 9, 2026 11:00 AM to approve unaudited results for quarter ended Dec 31, 2025; trading window closed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2006
from bse
-
Financial Year 2005
from bse
Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%
Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3